Literature DB >> 29884773

CDP-glycerol inhibits the synthesis of the functional O-mannosyl glycan of α-dystroglycan.

Rieko Imae1, Hiroshi Manya2, Hiroki Tsumoto3, Kenji Osumi4, Tomohiro Tanaka4, Mamoru Mizuno4, Motoi Kanagawa5, Kazuhiro Kobayashi5, Tatsushi Toda6, Tamao Endo1.   

Abstract

α-Dystroglycan (α-DG) is a highly glycosylated cell-surface laminin receptor. Defects in the O-mannosyl glycan of an α-DG with laminin-binding activity can cause α-dystroglycanopathy, a group of congenital muscular dystrophies. In the biosynthetic pathway of functional O-mannosyl glycan, fukutin (FKTN) and fukutin-related protein (FKRP), whose mutated genes underlie α-dystroglycanopathy, sequentially transfer ribitol phosphate (RboP) from CDP-Rbo to form a tandem RboP unit (RboP-RboP) required for the synthesis of the laminin-binding epitope on O-mannosyl glycan. Both RboP- and glycerol phosphate (GroP)-substituted glycoforms have recently been detected in recombinant α-DG. However, it is unclear how GroP is transferred to the O-mannosyl glycan or whether GroP substitution affects the synthesis of the O-mannosyl glycan. Here, we report that, in addition to having RboP transfer activity, FKTN and FKRP can transfer GroP to O-mannosyl glycans by using CDP-glycerol (CDP-Gro) as a donor substrate. Kinetic experiments indicated that CDP-Gro is a less efficient donor substrate for FKTN than is CDP-Rbo. We also show that the GroP-substituted glycoform synthesized by FKTN does not serve as an acceptor substrate for FKRP and that therefore further elongation of the outer glycan chain cannot occur with this glycoform. Finally, CDP-Gro inhibited the RboP transfer activities of both FKTN and FKRP. These results suggest that CDP-Gro inhibits the synthesis of the functional O-mannosyl glycan of α-DG by preventing further elongation of the glycan chain. This is the first report of GroP transferases in mammals.
© 2018 Imae et al.

Entities:  

Keywords:  CDP-glycerol; dystroglycan; enzyme catalysis; fukutin; glycobiology; glycosylation; glycosyltransferase; muscular dystrophy; protein glycosylation; α-dystroglycanopathy

Mesh:

Substances:

Year:  2018        PMID: 29884773      PMCID: PMC6078450          DOI: 10.1074/jbc.RA118.003197

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.

Authors:  Hiroshi Manya; Tamao Endo
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-07-12       Impact factor: 3.770

2.  The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.

Authors:  Hiroshi Manya; Yoshiki Yamaguchi; Motoi Kanagawa; Kazuhiro Kobayashi; Michiko Tajiri; Keiko Akasaka-Manya; Hiroko Kawakami; Mamoru Mizuno; Yoshinao Wada; Tatsushi Toda; Tamao Endo
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

3.  Glycerol Phosphate Cytidylyltransferase Stereospecificity Is Key to Understanding the Distinct Stereochemical Compositions of Glycerophosphoinositol in Bacteria and Archaea.

Authors:  Marta V Rodrigues; Nuno Borges; Helena Santos
Journal:  Appl Environ Microbiol       Date:  2016-12-15       Impact factor: 4.792

Review 4.  Recent advancements in understanding mammalian O-mannosylation.

Authors:  M Osman Sheikh; Stephanie M Halmo; Lance Wells
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

5.  Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Authors:  Alison K Esser; Michael R Miller; Qin Huang; Melissa M Meier; Daniel Beltran-Valero de Bernabé; Christopher S Stipp; Kevin P Campbell; Charles F Lynch; Brian J Smith; Michael B Cohen; Michael D Henry
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

6.  Expression, purification, and characterization of CTP:glycerol-3-phosphate cytidylyltransferase from Bacillus subtilis.

Authors:  Y S Park; T D Sweitzer; J E Dixon; C Kent
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

7.  Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes.

Authors:  Armin Akhavan; Obi L Griffith; Liliana Soroceanu; Dmitri Leonoudakis; Maria Gloria Luciani-Torres; Anneleen Daemen; Joe W Gray; John L Muschler
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

8.  The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation.

Authors:  Tobias Willer; Kei-Ichiro Inamori; David Venzke; Corinne Harvey; Greg Morgensen; Yuji Hara; Daniel Beltrán Valero de Bernabé; Liping Yu; Kevin M Wright; Kevin P Campbell
Journal:  Elife       Date:  2014-10-03       Impact factor: 8.140

9.  Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.

Authors:  Daniel Beltrán-Valero de Bernabé; Kei-Ichiro Inamori; Takako Yoshida-Moriguchi; Christine J Weydert; Hollie A Harper; Tobias Willer; Michael D Henry; Kevin P Campbell
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

Review 10.  Ribitol-phosphate-a newly identified posttranslational glycosylation unit in mammals: structure, modification enzymes and relationship to human diseases.

Authors:  Motoi Kanagawa; Tatsushi Toda
Journal:  J Biochem       Date:  2018-05-01       Impact factor: 3.387

View more
  9 in total

Review 1.  Laminin G-like domains: dystroglycan-specific lectins.

Authors:  Erhard Hohenester
Journal:  Curr Opin Struct Biol       Date:  2018-12-06       Impact factor: 6.809

2.  Cancer Malignancy Is Correlated with Upregulation of PCYT2-Mediated Glycerol Phosphate Modification of α-Dystroglycan.

Authors:  Fumiko Umezawa; Makoto Natsume; Shigeki Fukusada; Kazuki Nakajima; Fumiya Yamasaki; Hiroto Kawashima; Chu-Wei Kuo; Kay-Hooi Khoo; Takaya Shimura; Hirokazu Yagi; Koichi Kato
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 3.  Bilayer Forming Phospholipids as Targets for Cancer Therapy.

Authors:  Celine Stoica; Adilson Kleber Ferreira; Kayleigh Hannan; Marica Bakovic
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

Review 4.  Biosynthetic Mechanisms and Biological Significance of Glycerol Phosphate-Containing Glycan in Mammals.

Authors:  Rieko Imae; Hiroshi Manya; Tamao Endo
Journal:  Molecules       Date:  2021-11-04       Impact factor: 4.411

5.  CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model.

Authors:  Hideki Tokuoka; Rieko Imae; Hitomi Nakashima; Hiroshi Manya; Chiaki Masuda; Shunsuke Hoshino; Kazuhiro Kobayashi; Dirk J Lefeber; Riki Matsumoto; Takashi Okada; Tamao Endo; Motoi Kanagawa; Tatsushi Toda
Journal:  Nat Commun       Date:  2022-04-14       Impact factor: 17.694

6.  An embeddable molecular code for Lewis X modification through interaction with fucosyltransferase 9.

Authors:  Taiki Saito; Hirokazu Yagi; Chu-Wei Kuo; Kay-Hooi Khoo; Koichi Kato
Journal:  Commun Biol       Date:  2022-07-13

7.  Mix-and-Match System for the Enzymatic Synthesis of Enantiopure Glycerol-3-Phosphate-Containing Capsule Polymer Backbones from Actinobacillus pleuropneumoniae, Neisseria meningitidis, and Bibersteinia trehalosi.

Authors:  Christa Litschko; Insa Budde; Monika Berger; Andrea Bethe; Julia Schulze; E Alberto Alcala Orozco; Reza Mahour; Peter Goettig; Jana Indra Führing; Thomas Rexer; Rita Gerardy-Schahn; Mario Schubert; Timm Fiebig
Journal:  mBio       Date:  2021-05-26       Impact factor: 7.867

8.  Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy.

Authors:  Naoyuki Kuwabara; Rieko Imae; Hiroshi Manya; Tomohiro Tanaka; Mamoru Mizuno; Hiroki Tsumoto; Motoi Kanagawa; Kazuhiro Kobayashi; Tatsushi Toda; Toshiya Senda; Tamao Endo; Ryuichi Kato
Journal:  Nat Commun       Date:  2020-01-16       Impact factor: 14.919

9.  High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of α-dystroglycan.

Authors:  Maria Giulia Bigotti; Andrea Brancaccio
Journal:  Open Biol       Date:  2021-09-29       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.